FEMORAL DEROTATION OSTEOTOMY

This adverse event was reported 3 times

These drugs are most commonly taken by patients reporting FEMORAL DEROTATION OSTEOTOMY:

# Drug Count
0 ELOSULFASE ALFA 2
1 UPADACITINIB 1
See all common drugs associated with FEMORAL DEROTATION OSTEOTOMY

FEMORAL DEROTATION OSTEOTOMY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ELOSULFASE ALFA 2 0.0004
1 UPADACITINIB 1 0.0000
See all drugs enriched for association with FEMORAL DEROTATION OSTEOTOMY

These drug classes are most commonly taken by patients reporting FEMORAL DEROTATION OSTEOTOMY:

# Drug class Count
0 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2
1 Janus Kinase Inhibitor [EPC] 1
See all common drug classes associated with FEMORAL DEROTATION OSTEOTOMY

FEMORAL DEROTATION OSTEOTOMY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2 0.0001
1 Janus Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with FEMORAL DEROTATION OSTEOTOMY